Rapamune® (RAPA, rapamycin, sirolimus):: Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

被引:561
作者
Sehgal, SN [1 ]
机构
[1] Wyeth Ayerst Res, Princeton, NJ 08543 USA
关键词
rapamycin; sirolimus; cellular proliferation; immunosuppression; organ transplantation; signal transduction; mTOR; p70s6; kinase; PHAS; 1; cyclin-dependent kinases;
D O I
10.1016/S0009-9120(98)00045-9
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Rapamune is a novel immunosuppressive agent in Phase III clinical trial in renal transplantation. Its unique mechanism of action has created great interest in its use as a biochemical probe of signal transduction pathways that has provided insight into its molecular mechanism of action. This article reviews the current state of our understanding of the mechanism of action of rapamune. Copyright (C) 1998 The Canadian Society of Clinical Chemists.
引用
收藏
页码:335 / 340
页数:6
相关论文
共 69 条
[51]   Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo [J].
Nair, RV ;
Huang, X ;
Shorthouse, R ;
Adams, B ;
Brazelton, T ;
BraunDullaeus, R ;
Morris, RE .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :614-615
[52]   INTERLEUKIN-2-MEDIATED ELIMINATION OF THE P27(KIP1) CYCLIN-DEPENDENT KINASE INHIBITOR PREVENTED BY RAPAMYCIN [J].
NOURSE, J ;
FIRPO, E ;
FLANAGAN, WM ;
COATS, S ;
POLYAK, K ;
LEE, MH ;
MASSAGUE, J ;
CRABTREE, GR ;
ROBERTS, JM .
NATURE, 1994, 372 (6506) :570-573
[53]   RAPAMYCIN-INDUCED INHIBITION OF THE 70-KILODALTON S6 PROTEIN-KINASE [J].
PRICE, DJ ;
GROVE, JR ;
CALVO, V ;
AVRUCH, J ;
BIERER, BE .
SCIENCE, 1992, 257 (5072) :973-977
[54]  
Sabatini D. M., 1995, Society for Neuroscience Abstracts, V21, P1128
[55]   THE RAPAMYCIN AND FKBP12 TARGET (RAFT) DISPLAYS PHOSPHATIDYLINOSITOL 4-KINASE ACTIVITY [J].
SABATINI, DM ;
PIERCHALA, BA ;
BARROW, RK ;
SCHELL, MJ ;
SNYDER, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (36) :20875-20878
[56]  
SABERS C, 1994, J BIOL CHEM, V270, P815
[57]  
SCHMANDT R, 1994, J IMMUNOL, V152, P96
[58]   ABROGATION BY RAPAMYCIN OF ACCELERATED REJECTION IN SENSITIZED RATS BY INHIBITION OF ALLOANTIBODY RESPONSES AND SELECTIVE SUPPRESSION OF INTRAGRAFT MONONUCLEAR AND ENDOTHELIAL-CELL ACTIVATION, CYTOKINE PRODUCTION, AND CELL-ADHESION [J].
SCHMIDBAUER, G ;
HANCOCK, WW ;
WASOWSKA, B ;
BADGER, AM ;
KUPIECWEGLINSKI, JW .
TRANSPLANTATION, 1994, 57 (06) :933-941
[59]   RAPAMYCIN - A NOVEL IMMUNOSUPPRESSIVE MACROLIDE [J].
SEHGAL, SN ;
MOLNARKIMBER, K ;
OCAIN, TD ;
WEICHMAN, BM .
MEDICINAL RESEARCH REVIEWS, 1994, 14 (01) :1-22
[60]   RAPAMYCIN - IN-VITRO PROFILE OF A NEW IMMUNOSUPPRESSIVE MACROLIDE [J].
SEHGAL, SN ;
BANSBACH, CC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 685 :58-67